Research Article

An In Silico Study of the Interactions of Alkaloids from Cryptolepis sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase

Table 2

Molecular docking result of pyrimethamine and Cryptolepis sanguinolenta alkaloids with wild-type PfDHFR (3QGT).

AlkaloidsBinding energies (kcal/mol)Hydrogen bond interactionsHydrophobic interactions

Redocked pyrimethamine−8.00Ile14, Cys15, Asp54, Ser108, Ile112, Thr185Ala16, Met55, Phe58, Ile164
Biscryptolepine−12.9Ala16, Val45, Leu46, Ser111, Ile112
Cryptomisrine−13.4Ser108Leu40, Val45, Leu46, Ser111, Leu119, Ile112, Pro113
Cryptolepicarboline−12.0Ala16, Leu46, Ser111, Ile112, Ile164
Cryptoquindoline−13.0Ala16, Val45, Leu46, Ser111, Ile112
Cryptospirolepine−8.80Val45, Leu46, Lys49, Met55, Ser111, Pro113
Cryptolepinone−8.80Ser108Leu40, Phe58, Ile164, Tyr170, Val195
11-isopropylcryptolepine−8.80Ala16, Leu40, Leu46, Ile112, Tyr170
Cryptoheptine−8.50Asp54Ala16, Leu46, Met55, Phe58
Cryptolepine−8.50Asp54Ala16, Met55, Phe58, Ile112
Hydroxycryptolepine−8.40Asp54, Met55Ala16, Phe58, Ile112
Isocryptolepine−8.30Gly44, Leu40, Phe58, Ile164
Neocryptolepine−8.30Ala16, Met55, Phe58, Ile112, Ile164